We are live on
!
Find out more
JWBC
J.W. Burns & Co Portfolio holdings
AUM
$959M
Turnover
9.23%
1-Year Est. Return
25.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.84%
1 Year Est. Return
+25.08%
3 Year Est. Return
+78.47%
5 Year Est. Return
+103.81%
10 Year Est. Return
+394.19%
AUM
$363M
AUM Growth
+$21.9M
(+6.4%)
Cap. Flow
+$4.73M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
28.36%
Holding
165
New
8
Increased
49
Reduced
75
Closed
3
Avg Time Held
2.8
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.56M |
| 3 |
MetLife
MET
|
+$1.52M |
| 4 |
FedEx
FDX
|
+$1.07M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$952K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$3.05M |
| 2 |
Gilead Sciences
GILD
|
+$1.84M |
| 3 |
Hanesbrands
HBI
|
+$835K |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$563K |
| 5 |
Yum China
YUMC
|
+$545K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.76% |
| 2 | Miscellaneous | 14.65% |
| 3 | Consumer Staples | 12.36% |
| 4 | Financials | 12.18% |
| 5 | Technology | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Comcast
CMCSA
$77.3B
| $227K | 0.06% |
6,047
-1
| -0% | -$37 |
2016 Q4
1 quarter
|
|
152
iShares US Technology ETF
IYW
$25.8B
| $221K | 0.06% |
+6,540
| New | +$212K |
2017 Q1
0 quarters
|
|
153
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
| $218K | 0.06% |
3,993
-105
| -3% | -$5.88K |
2016 Q4
1 quarter
|
|
|
AGN
154
DELISTED
Allergan plc
AGN
| $215K | 0.06% |
+900
| New | +$210K |
2017 Q1
0 quarters
|
|
155
State Street
STT
$46B
| $213K | 0.06% |
2,677
| – | – |
2016 Q4
1 quarter
|
|
156
Annaly Capital Management
NLY
$13.9B
| $193K | 0.05% |
4,352
-749
| -15% | -$31.9K |
2013 Q2
15 quarters
|
|
157
DELISTED
SunPower Corporation Common Stock
SPWR
| $115K | 0.03% |
28,860
-3,818
| -12% | -$17.9K |
2014 Q4
9 quarters
|
|
158
TherapeuticsMD
TXMD
$22.3M
| $107K | 0.03% |
298
-10
| -3% | -$3.1K |
2016 Q2
3 quarters
|
|
|
FTR
159
DELISTED
Frontier Communications Corp.
FTR
| $22K | 0.01% |
693
| – | – |
2015 Q3
6 quarters
|
|
|
160
CSX Corp
CSX
$90.2B
| – | – |
-254,808
| Closed | -$3.05M | – |
|
161
iShares Mortgage Real Estate ETF
REM
$460M
| – | – |
-7,000
| Closed | -$294K | – |
|
|
ESRX
162
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-8,182
| Closed | -$563K | – |
|
|
NT
163
DELISTED
NORTEL NETWORKS CRP(HLDG CO) NEW
NT
| $0 | ﹤0.01% |
10,010
| – | – |
2015 Q2
7 quarters
|
|
Similar funds
RAM
AAP
WI
PL
SCM
LGP
BWS
LAM
J.W. Burns & Co's Q1 2017 Portfolio in Review
As of Q1 2017, J.W. Burns & Co held 165 positions worth $363M, up 6.4% from $341M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
J.W. Burns & Co's Q1 2017 filing shows 8 new, 49 increased, 75 reduced and 3 closed positions. Its largest new stake was MetLife: 31,910 shares worth $1.5M. The largest sale was CSX Corp, an estimated $3.05M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Miscellaneous and Consumer Staples.
- J.W. Burns & Co's largest Q1 2017 buy was MetLife: 31,910 shares worth $1.5M.
- J.W. Burns & Co added most to Celgene Corp in Q1 2017, an estimated $1.6M increase.
- J.W. Burns & Co's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $1.84M.
- J.W. Burns & Co fully exited CSX Corp in Q1 2017, selling an estimated $3.05M.
- J.W. Burns & Co's ten largest holdings make up 28% of its $363M portfolio in Q1 2017.
- J.W. Burns & Co opened 8 new positions and closed 3 in Q1 2017.
- J.W. Burns & Co's portfolio value rose 6.4% quarter-over-quarter to $363M.
Based on J.W. Burns & Co's 13F filing for Q1 2017, filed 6 Apr 2017.